Adimab Announces Expansion of its Collaboration with GSK for the Discovery of Bispecific Antibodies

Adimab, LLC, a technology leader in the discovery of fully human antibodies and bispecifics, today announced that GlaxoSmithKline (GSK) has broadened its relationship with Adimab. Under an expanded collaboration, Adimab will build a unique custom library for GSK for use in generating bispecific antibody leads. Adimab will use that library as well as existing Adimab [...]

By |2016-04-26T16:19:53-04:00January 12th, 2015|Dartmouth Innovation, New Hampshire, News|

Adimab Announces New Partnerships with Acceleron, Oncothyreon, Surface Oncology and Potenza

Adimab, LLC, the technology leader in the discovery of monoclonal and bispecific antibodies, today announced independent discovery collaborations with Acceleron Pharma, Inc., Oncothyreon, Inc., Surface Oncology, Inc. and Potenza Therapeutics, Inc. All four collaborations are structured as funded discovery programs in which Adimab will discover and optimize therapeutic monoclonal or bispecific antibodies against multiple targets for [...]

By |2016-04-26T16:20:18-04:00January 9th, 2015|Dartmouth Innovation, New Hampshire, News|